Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 3.07 M3.84 M — Research & development 3.39 M6.09 M — Operating income 4.65 M8.02 M — Non-Operating Income, Total 26 K98 K — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 15 K64 K — Unusual income/expense 11 K34 K — Pretax income 4.63 M7.92 M — Equity in earnings —— — Taxes 00 — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 4.63 M7.92 M — Discontinued operations —— — Net income 4.63 M7.92 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 4.63 M7.92 M — Basic earnings per share (Basic EPS) -2.02-0.17 — Diluted earnings per share (Diluted EPS) -2.02-0.17 — Average basic shares outstanding 2.29 M46.22 M — Diluted shares outstanding 2.29 M46.22 M — EBITDA -4.6 M-7.96 M — EBIT -4.65 M-8.02 M — Cost of revenue 1.5 M1.62 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 55 K54 K —